Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeraphim Space Regulatory News (SSIT)

Share Price Information for Seraphim Space (SSIT)

Share Price is delayed by 15 minutes
Get Live Data
187.00    -0.40 (-0.21%)
Bid:
186.60
Ask:
188.00
Spread: 1.40 (0.75%)
Market Cap: £443.56m
SSIT Live PriceLast checked at - London Stock Exchange

Intraday Seraphim Space Share Chart

Update from QuotedData

4 Dec 2025 16:15

RNS Number : 3407K
Seraphim Space Investment Trust PLC
04 December 2025
 

Seraphim Space Investment Trust - Update from QuotedData

5 December 2025

Dual-use SpaceTech: a strategic shift, not a short-term trend

Rising global defence spending, with many NATO countries now meeting or exceeding previous commitments, has made SpaceTech a higher priority for governments and major contractors. This shift in priorities is feeding directly into the commercial market. Investment in SpaceTech is also rebounding, with $10.4bn raised in the third quarter of 2025, close to the $10.9bn peak in the second quarter of 2021.

Seraphim Space Investment Trust (SSIT) is well positioned in dual-use SpaceTech and has seen strong NAV growth over the last year, helped by valuation uplifts across a number of core holdings. With several of SSIT's companies showing revenue growth, we believe there could be much more to come. This could help reduce SSIT's mid-30s discount to net asset value (NAV), which we see as far too wide.

Full Research:

https://quoteddata.com/research/seraphim-space-investment-trust-dual-use-spacetech-a-strategic-shift-not-a-short-term-trend-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Seraphim Space Investment Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUSRNRVWUURAA
Date   Source Headline
3rd Jun 20267:00 amRNS3rd Quarter Results
1st Jun 20267:00 amRNSTotal Voting Rights
22nd May 20267:00 amRNSNotice of Results
15th May 20264:16 pmRNSDirector/PDMR Shareholding
14th May 202610:19 amRNSDirector/PDMR Shareholding
14th May 202610:19 amRNSDirector/PDMR Shareholding
14th May 202610:18 amRNSDirector/PDMR Shareholding
14th May 20269:42 amRNSDirector/PDMR Shareholding
13th May 20263:06 pmRNSHolding(s) in Company
12th May 202610:27 amRNSHolding(s) in Company
8th May 20267:00 amRNSResults of Equity Raise
7th May 20262:35 pmRNSRevised announcement: Launch of equity raise
7th May 20261:20 pmRNSHawkeye 360 IPO
6th May 20262:24 pmRNSResult of General Meeting
5th May 20267:00 amRNS-RSpaceTech Sector Newsletter - April 2026
1st May 20261:41 pmRNS-RInvestor Presentation via Investor Meet Company.
30th Apr 20262:35 pmRNSAcquisition of ALL.SPACE by York Space Systems
30th Apr 20267:00 amRNS-RUpdate research from QuotedData
28th Apr 20267:00 amRNSPortfolio Update: HawkEye 360
27th Apr 20267:02 amRNSLaunch of Retail Offer
27th Apr 20267:00 amRNSLaunch of Equity Raise
24th Apr 202612:24 pmRNSHolding(s) in Company
17th Apr 202611:57 amRNSDirector Declaration
16th Apr 20267:00 amRNSCircular and Notice of General Meeting
13th Apr 20267:00 amRNSContemplating fundraising via an issue of C shares
9th Apr 20267:00 amRNS-RSpaceTech Sector Newsletter – March 2026
26th Mar 202612:31 pmRNSValuation Update - Xona Space Systems
12th Mar 202610:33 amRNS-RQuotedData's In The HotSeat
12th Mar 202610:33 amRNS-RQuotedData's In The HotSeat
5th Mar 20267:00 amRNSInterim Results
4th Mar 20267:00 amRNS-RSpaceTech Sector Newsletter - February 2026
16th Feb 20267:00 amRNSValuation Uplift & Notice of Results
9th Feb 20267:00 amRNS-RSpaceTech Sector Newsletter - January 2026
8th Jan 20267:00 amRNS-RSpaceTech Sector Newsletter - December 2025
19th Dec 20257:00 amRNSICEYE and Rheinmetall Sign €1.7 billion Contract
19th Dec 20257:00 amRNSICEYE and Rheinmetall Sign €1.7 billion Contract
4th Dec 20254:15 pmRNS-RUpdate from QuotedData
4th Dec 20257:00 amRNS-RSpaceTech Sector Newsletter – November 2025
25th Nov 20253:17 pmRNSDirector/PDMR Shareholding
25th Nov 20253:12 pmRNSDirector/PDMR Shareholding
25th Nov 20251:11 pmRNSResult of AGM
25th Nov 20257:00 amRNSFirst Quarter Results
5th Nov 202511:08 amRNS-RSpaceTech Sector Newsletter–October 2025-Amendment
5th Nov 20257:00 amRNS-RSpaceTech Sector Newsletter – October 2025
30th Oct 20257:00 amRNSNotice of Results
24th Oct 20259:36 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSNotice of AGM
20th Oct 20257:00 amRNSFull Year Results
2nd Oct 20257:00 amRNS-RSpaceTech Sector Newsletter – September 2025
24th Sep 20259:58 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.